NME
Notis-McConarty Edward Portfolio holdings
AUM
$205M
This Quarter Return
+2.76%
1 Year Return
+14.8%
3 Year Return
+72.99%
5 Year Return
+119.96%
10 Year Return
+295.3%
AUM
$169M
AUM Growth
+$169M
(+1.1%)
Cap. Flow
-$1.59M
Cap. Flow
% of AUM
-0.94%
Top 10 Holdings %
Top 10 Hldgs %
35.22%
Holding
86
New
–
Increased
19
Reduced
45
Closed
1
Top Buys
| 1 |
RTX Corp
RTX
|
$347K |
| 2 |
Danaher
DHR
|
$155K |
| 3 |
Home Depot
HD
|
$133K |
| 4 |
Chubb
CB
|
$126K |
| 5 |
Analog Devices
ADI
|
$117K |
Top Sells
| 1 |
GE Aerospace
GE
|
$304K |
| 2 |
Mastercard
MA
|
$291K |
| 3 |
Oracle
ORCL
|
$286K |
| 4 |
Starbucks
SBUX
|
$227K |
| 5 |
COL
Rockwell Collins
COL
|
$135K |
Sector Composition
| 1 | Technology | 25.33% |
| 2 | Healthcare | 24.33% |
| 3 | Industrials | 15.01% |
| 4 | Financials | 8.06% |
| 5 | Consumer Staples | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
JPMorgan Chase
JPM
$829B
| $1.96M | 1.16% |
18,772
| – | – |
|
27
PepsiCo
PEP
$204B
| $1.88M | 1.11% |
17,241
-200
| -1% | -$21.8K |
|
28
Illumina
ILMN
$15.8B
| $1.76M | 1.04% |
6,285
+2
| +0% | +$558 |
|
|
CELG
29
DELISTED
Celgene Corp
CELG
| $1.62M | 0.96% |
20,389
+1,111
| +6% | +$88.2K |
|
|
XLNX
30
DELISTED
Xilinx Inc
XLNX
| $1.56M | 0.92% |
23,865
+220
| +0.9% | +$14.4K |
|
31
NVIDIA
NVDA
$4.24T
| $1.48M | 0.88% |
6,250
-25
| -0.4% | -$5.92K |
|
32
Lowe's Companies
LOW
$145B
| $1.48M | 0.87% |
15,450
-350
| -2% | -$33.4K |
|
|
33
Oracle
ORCL
$635B
| $1.46M | 0.86% |
33,050
-6,487
| -16% | -$286K |
|
34
Union Pacific
UNP
$133B
| $1.38M | 0.82% |
9,750
-300
| -3% | -$42.5K |
|
35
Emerson Electric
EMR
$74.3B
| $1.36M | 0.8% |
19,650
-1,000
| -5% | -$69.1K |
|
36
Honeywell
HON
$139B
| $1.35M | 0.8% |
9,399
-250
| -3% | -$36K |
|
37
Chevron
CVX
$324B
| $1.34M | 0.8% |
10,630
-300
| -3% | -$37.9K |
|
38
Cisco
CSCO
$274B
| $1.34M | 0.79% |
31,090
-200
| -0.6% | -$8.61K |
|
39
Merck
MRK
$210B
| $1.34M | 0.79% |
21,980
-250
| -1% | -$15.2K |
|
40
Stryker
SYK
$150B
| $1.23M | 0.73% |
7,250
-275
| -4% | -$46.5K |
|
41
DuPont de Nemours
DD
$32.2B
| $1.2M | 0.71% |
18,126
| – | – |
|
42
Bristol-Myers Squibb
BMY
$96B
| $1.19M | 0.71% |
21,511
| – | – |
|
43
Qualcomm
QCOM
$173B
| $1.17M | 0.69% |
20,845
| – | – |
|
44
Xylem
XYL
$34.5B
| $1.14M | 0.68% |
16,945
-350
| -2% | -$23.6K |
|
45
Fortive
FTV
$16.2B
| $1.13M | 0.67% |
14,592
+800
| +6% | +$61.7K |
|
46
Diageo
DEO
$62.1B
| $1.1M | 0.65% |
7,665
-200
| -3% | -$28.8K |
|
47
Gilead Sciences
GILD
$140B
| $1.06M | 0.63% |
14,942
-330
| -2% | -$23.4K |
|
48
Colgate-Palmolive
CL
$67.9B
| $962K | 0.57% |
14,840
-195
| -1% | -$12.6K |
|
49
Accenture
ACN
$162B
| $953K | 0.56% |
5,825
| – | – |
|
50
Pembina Pipeline
PBA
$21.9B
| $927K | 0.55% |
26,800
| – | – |
|